UK approves COVID-19 vaccine for emergency use

COVID-19 vaccines

The UK government becomes the first to approve the BioNTech/Pfizer vaccine against COVID-19 for emergency use, following the recommendation of the national medicines regulator.

The request for emergency authorization was submitted by BioNTech and Pfizer to the MHRA last month — as well as to regulators in other countries like Australia, Canada, Europe, Japan and the U.S.

However, none of this other countries has given the go ahead for the new COVID-19 vaccine.

Chairman and CEO of Pfizer Albert Bourla said in a statement that the Emergency Use Authorization in the U.K. is “a historic moment in the fight against COVID-19”.

The UK has gone on to ordered 40M doses of the BioNTech/Pfizer vaccine, which is expected to be enough vaccine for 20M people (as it requires two doses).

Boris Johnson has expressed optimism on the efficacy of the vaccine saying it will help the people get their lives back and get the economy going again.

Social Media Auto Publish Powered By :